Discovery of diarylurea P2Y1 antagonists with improved aqueous solubility
Preclinical data suggests that P2Y1 antagonists, such as diarylurea compound 1, may provide antithrombotic efficacy similar to P2Y 12 antagonists and may have the potential of providing reduced bleeding liabilities. This manuscript d
Wang, Tammy C.,Qiao, Jennifer X.,Clark, Charles G.,Jua, Ji,Price, Laura A.,Wu, Qimin,Chang, Ming,Zheng, Joanna,Huang, Christine S.,Everlof, Gerry,Schumacher, William A.,Wong, Pancras C.,Seiffert, Dietmar A.,Stewart, Anne B.,Bostwick, Jeffrey S.,Crain, Earl J.,Watson, Carol A.,Rehfuss, Robert,Wexler, Ruth R.,Lam, Patrick Y.S.
p. 3239 - 3243
(2013/06/27)
More Articles about upstream products of 870545-80-5